Cholesterol Disorders

January 03, 2021

This article features the top 6 stories in Practical Cardiology's coverage of lipid management in 2020.

December 28, 2020

Practical Cardiology Advisory Board Member Brett Nowlan, MD, offers his perspective on the most important advances and topics in the field of lipidology from 2020.

December 23, 2020

The US FDA has declined to approve inclisiran ahead of its PDUFA date of December 23, instead issuing a CRL citing unresolved facility inspection issues.

December 17, 2020

Learn more about the importance of educating patients on the differences between store-bought fish oil supplements and therapies derived from omega-3 such as icosapent ethyl (Vascepa).

December 04, 2020

New research from the Mayo Clinic is outlining the successes and pitfalls of efforts to improve statin adherence in a comparison of data from the OptumLab Data Warehouse from 2007-2016.

November 27, 2020

Dr. Paul D. Thompson tackles the topic of whether use of fenofibrate helps or harms kidney function.

November 16, 2020

Data from a phase 2 trial suggests evinacumab, in both subcutaneous and intravenous doses, were effective at lowering LDL-C in patients with refractory hypercholesterolemia.

November 09, 2020

Practical Cardiology's Chief Advisory Board member Dr. Guy Mintz and a principal investigator from the CLEAR program discuss bempedoic acid and how they envision it fitting into treatment algorithms going forward.

November 05, 2020

An analysis of more than 2k patients from hospitals in Spain detail associations between statin use and lower rates of COVID-19 mortality.

October 30, 2020

An analysis of data from patients presenting to a medical center in New York City details associations between statin use and mortality among diabetics hospitalized with COVID-19.

October 22, 2020

In a recent column, Paul Thompson, MD, reviews an email exchange he had with a colleague seeking perspective for a patient with statin-induced autoimmune myopathy.

October 20, 2020

In a submitted column, Dr. Gregory Weiss reflects on the importance of adherence to cholesterol-lowering medications and including statins in treatment regimens.

October 18, 2020

Results of REDUCE-IT PCI detail a 34% reduction in 5-point MACE and a 39% reduction in total events among patients receiving icosapent ethyl (Vascepa) in the original trial with a history of PCI.

October 08, 2020

A Penn Medicine study found addition of prompts to an EHR did not significantly change the percentage of patients prescribed a statin.

September 21, 2020

Chief member of Practical Cardiology's editorial advisory board discusses his approach to cholesterol education and the current state of cholesterol management in 2020.

September 18, 2020

A meta-analysis of more than 3 dozen RCTs suggests increased intake of omega-3 supplements, such as EPA and DHA, was linked to a decreased risk of myocardial infarction action and coronary heart disease events.

September 17, 2020

With September recognized as National Cholesterol Education Month, Dr. Weiss reflects on the importance of cholesterol management as part of mitigating risk of events in patients with ASCVD.

September 05, 2020

Paul Thompson, MD, offers perspective on the use of ezetimibe in a clinical setting.

September 04, 2020

Deepak Bhatt, MD, of Brigham and Women's Hospital, offers perspective on REDUCE-IT analyses and icosapent ethyl (Vascepa) data presented at ESC Congress 2020.

September 03, 2020

A podcast featuring an interview with Prof. Kausik Ray centered around the latest inclisiran data presented at ESC Congress 2020.